Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Indian Agency Fines Ranbaxy Unit For Late Lab Report After Patient Death

This article was originally published in PharmAsia News

Executive Summary

An Indian agency ordered Ranbaxy Laboratories to pay a fine of $1,165 to an Indian family for failing to issue a test report on time. The fine was ordered by the Delhi State Consumer Disputes Redressal Commission against Specialty Ranbaxy to pay the family after a member died awaiting a crucial medical test needed before surgery. The court said Ranbaxy took 25 days to produce the report, after the patient had died. Conflicting pathological laboratory results led to the request from Specialty Ranbaxy's lab. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068711

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel